AYTU BIOPHARMA, INC. (AYTU) Gross profit 2017–2026
AYTU BIOPHARMA, INC. (AYTU) annual gross profit history from SEC filings — each fiscal year as reported.
$36.8MFY2026 · since FY2017: $1.8M → $36.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $36.8M | -19.7% |
| FY2025 | $45.8M | -6.6% |
| FY2024 | $49.1M | -26.4% |
| FY2023 | $66.6M | +27.4% |
| FY2022 | $52.3M | +79.1% |
| FY2021 | $29.2M | +50.9% |
| FY2020 | $19.4M | +278.1% |
| FY2019 | $5.1M | +218.0% |
| FY2018 | $1.6M | -10.8% |
| FY2017 | $1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AYTU financial trends
AYTU RevenueAYTU Net incomeAYTU Net marginAYTU Gross marginAYTU Operating incomeAYTU Operating marginAYTU Operating cash flowAYTU Free cash flowAYTU Capital expendituresAYTU Return on equityAYTU Stock buybacksAYTU Dividends paidAYTU Total assetsAYTU Total liabilitiesAYTU Shareholders’ equityAYTU overview →